申请人:Monsanto Company
公开号:US05321153A1
公开(公告)日:1994-06-14
This invention is selected novel chiral (essentially pure) alpha-amino phosphonates, process for the preparation which is a catalytic asymmetric hydrogenation of olefins and novel intermediates therefor. The alpha-amino phosphonates are useful as antibiotics and/or as intermediates in the preparation of phosphorus-containing analogs of peptides, i.e., phosphonopeptides or pseudopeptides having known uses, such as in antibiotics, antibiotic enhancers, or enzyme inhibitors.
这项发明选取了新颖的手性(基本纯的)α-氨基膦酸酯,其制备过程是烯烃的催化不对称氢化,以及相关的新型中间体。这些α-氨基膦酸酯可用作抗生素和/或用作含磷肽类的类似物的制备中间体,即具有已知用途的磷酸酯肽或伪肽,如抗生素、抗生素增效剂或酶抑制剂。